浅地 正吾Asaji, Shogo

オブカウンセル

東京 + 81.3.6744.1612

浅地正吾は、知的財産法および訴訟の分野において20年以上の経験を有しています。浅地は、工学のバックグラウンドを持ち、日英バイリンガルで、数百万ドル規模のグローバルな特許紛争を日米両国で取り扱った経験を有する、日本では数少ない米国弁護士の一人です。

浅地の主な取扱分野は、知的財産訴訟、知的財産に関するカウンセリング、法律意見の作成、ライセンスに関する助言、および国際的なビジネスと契約に関連する紛争です。浅地は、米国裁判所や米国国際貿易委員会(ITC)における訴訟(ハッチ・ワックスマン/ANDA訴訟を含む。)、米国特許商標庁(USPTO)における行政手続においてクライアントを代理しています。彼は、無線通信、ソフトウェア、ユーザーインターフェース技術、発光ダイオード、液晶ディスプレイ、トランジスタ、半導体および半導体製造、データ記憶装置、データベース、ネットワーク、ビジネス方法、DVD、デジタルプロジェクター、ポリマー、低分子化合物、成長ホルモン、抗体、抗体製剤、抗ウイルス剤、ワクチン、難燃剤、有機溶剤、インスリン注射器具など、さまざまな技術を効果的に取り扱ってきました。

浅地は、東京で弁護士業務を行う前は、ニューヨークで弁護士業務を行っていました。弁護士になる前は、国内の中堅企業の役員を務めた経験もあります。スイスとフランスで育ち、フランス語での業務も可能です。

浅地は、現在東京オフィスでは共同採用担当およびプロボノ担当を務めています。2018年から2019年までは、Tokyo IP American Inn of Courtの理事長を務めていました。

担当案件


  • Japanese wire manufacturer and its U.S. subsidiary defend against alleged patent infringement regarding wire technologyJones Day secured a final judgment of non-infringement and invalidity in favor of a Japanese wire manufacturer and its U.S. subsidiary in a patent infringement case related to coil wire technology in the Central District of California.
  • Kyowa Hakko Kirin and BioWa successfully enforce patent rights on antibody technologyJones Day, on behalf of Japanese life sciences company Kyowa Hakko Kirin Company, Limited ("KHK") and its wholly-owned U.S. subsidiary, BioWa, successfully settled a patent infringement suit over three of KHK's patents that underlie KHK's award-winning POTELLIGENT® technology capable of producing therapeutic antibodies with dramatically improved potency and efficacy.
  • Kyowa Hakko Kirin defeats competitors in Patent Trial and Appeal Board challenge of patents on antibody technologyOn October 23, 2017, the Patent Trial and Appeal Board ("PTAB") issued a trio of decisions, unanimously declining to institute inter partes review ("IPR") of three patents owned by a Japanese pharmaceutical company represented by Jones Day, Kyowa Hakko Kirin Co., Ltd.
  • Akebia obtains favorable preliminary decision in invalidity proceedings at JPOJones Day's client Akebia Therapeutics, Inc. received a preliminary trial decision in connection with a patent invalidation proceeding at the Japan Patent Office.
  • The following represents experience prior to joining Jones Day.



    Smartphone Litigation (Tokyo District Court, Japan IP High Court, and Japan Patent Office). Member of team that successfully asserted an user-interface patent and defended against assertions of declared standards-essential patents in Japan as part of a high profile global dispute.



    Toshiba Corp. v. Imation Corp., et al. (Western District of Wisconsin). Represented Toshiba Corp. in enforcing patents covering DVD technology against disc manufacturers and sellers. The jury found infringement.



    AAA/ICDR Arbitration(New York). Represented a Japanese heavy equipment manufacturer in an ICDR arbitration against a U.S. aircraft leasing company.



    Albemarle Corp. v. Kaneko Chemical Co., Ltd. (Tokyo District Court, Japan IP High Court, and Japan Patent Office). Represented Albemarle Corp. for a patent infringement case against a Japanese chemical company.



    Seoul Semiconductor Co. v. Nichia Corporation et al. (Eastern District of Texas). Represented Nichia Corp. against assertions of infringement of short-wavelength laser diode and LED patent. The case settled shortly after the Markman hearing.



    Nishiyama v. Oracle Corp. (Japan Patent Office). Obtained an opinion of noninfringement for Oracle Corp. at the JPO after patentee sought an advisory opinion of infringement by the client's in-memory data grid product.



    Portable Music Player Litigation (Tokyo Customs Office, Japan). Defeated petition for import ban of U.S. client's portable music players based on allegations of patent infringement.



    Lund LLC v. Fujitsu Computer Systems Corp. et al. (Eastern District of Texas). Represented Fujitsu is a patent infringement lawsuit brought by an individual inventor against Fujitsu’s laptop computers. The case settled.



    Compression Labs Incorporated v. Fujitsu Computer Products of America et. al. (Eastern District of Texas). Represented Fujitsu in a patent infringement lawsuit concerning JPEG/MPEG compression technologies.



    TAP Pharmaceutical Products, Inc., et al. v. Owl Pharmaceuticals, L.L.C., et al. (Northern District of Ohio). Represented co-plaintiff Takeda Chemical Industries in ANDA litigation relating to sustained-release formulations for treating prostate cancer. The district court found infringement and the Court of Appeals for the Federal Circuit affirmed the district court's judgment.



    In re '639 Patent Litigation (District of Massachusetts). Represented plaintiff GlaxoSmithKline in ANDA litigation against generic manufacturers of a NSAID in trial and on appeal.



    University of Rochester v. G.D. Searle Co., Inc. et al. (Western District of New York). Represented G.D. Searle and Pharmacia in a billion dollar patent infringement suit relating to G.D. Searle and Pharmacia’s Celebrex®. The district court granted summary judgment in favor of the clients and the Federal Circuit affirmed.



    DepoMed, Inc. v. Bristol-Myers Squibb Co. (Northern District of California). Represented Bristol-Myers Squibb in a patent and trade secret case involving extended release formulation for diabetes drug Glucophage®. The case settled.



    Novo Nordisk A/S et al. v. Becton Dickinson & Co. (Southern District of New York). Represented Becton Dickinson in a patent infringement lawsuit alleging infringement of several patents relating to insulin injection systems. The jury returned a verdict in favor of the client.

    セミナー・講演

    • March 2018
      Legal Enhancement Expert Program Academy:米国特許訴訟における最新事情
    • September 27, 2017
      AIPPI Seminar 2017
    • September 2017
      AIPPI JAPANセミナー:米国特許訴訟の最新情報
    • June 2017
      ジョーンズ・デイ ライフサイエンスセミナー:ライフサイエンス企業の米国における事業活動に関連する判例法の展開
    • May2017
      ジョーンズ・デイEUセミナー: 欧州における各法分野の最新動向と留意点
    • October 2016
      米国特許侵害訴訟セミナー
    • April 2016
      AIPPI JAPANセミナー:米国特許訴訟の最新情報
    • April 8, 2016
      Recent Case Law Concerning FRAND Licensing & Standard Essential Patents (SEPs)
    • April 7, 2016
      Recent Case Law Concerning FRAND Licensing & Standard Essential Patents (SEPs)
    • September 2015
      ジョーンズ・デイ米国訴訟セミナー:米国訴訟において日本の企業が留意すべき事項
    • May 2015
      ジョーンズ・デイ米国訴訟セミナー:米国訴訟において日本の企業が留意すべき事項
    • December 2014
      AIPPI JAPANセミナー:米国特許訴訟の最新情報
    • December 12, 2014
      AIPPI Seminar 2014
    *We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.